Baxter (BAX) Gets FDA Approval for ADVATE 4000 IU Dosage Strength
Go back to Baxter (BAX) Gets FDA Approval for ADVATE 4000 IU Dosage Strength| Baxter International Inc. (NYSE: BAX) | Delayed: 26.64 +0.70 (2.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.94 | 52 Week High | $50.16 | |||
| Open | $26.04 | 52 Week Low | $34.06 | |||
| Day High | $26.75 | P/E | 7.28 | |||
| Day Low | $25.87 | EPS | $3.66 | |||
| Volume | 5,053,188 | |||||
